166 related articles for article (PubMed ID: 23072245)
21. Hodgkin lymphoma following adalimumab for the treatment of Crohn's disease in an adolescent.
Rodriguez AA; Kerner J; Luna-Fineman S; Berry GJ
Dig Dis Sci; 2014 Oct; 59(10):2403-5. PubMed ID: 24817339
[No Abstract] [Full Text] [Related]
22. Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab.
Tursi A
Acta Gastroenterol Belg; 2013 Jun; 76(2):264-5. PubMed ID: 23898572
[No Abstract] [Full Text] [Related]
23. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
[TBL] [Abstract][Full Text] [Related]
24. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
[No Abstract] [Full Text] [Related]
25. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
Jürgens M; Brand S; Filik L; Hübener C; Hasbargen U; Beigel F; Tillack C; Göke B; Ochsenkühn T; Seiderer J
Inflamm Bowel Dis; 2010 Oct; 16(10):1634-6. PubMed ID: 20027647
[No Abstract] [Full Text] [Related]
26. Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review.
Da W; Zhu J; Wang L; Lu Y
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):885-91. PubMed ID: 23817447
[TBL] [Abstract][Full Text] [Related]
27. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
[No Abstract] [Full Text] [Related]
28. Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab.
Nancey S; Boschetti G; Cotte E; Cathey-Javouhay A; Laidet M; Chichery A; Francois Y; Glehen O; Flourié B
Inflamm Bowel Dis; 2011 Apr; 17(4):1060-1. PubMed ID: 21391289
[No Abstract] [Full Text] [Related]
29. [Adalimumab in Crohn's disease - data from real life].
López San Román A; Van Domselaar M; Garrido E
Rev Esp Enferm Dig; 2008 Nov; 100(11):671-5. PubMed ID: 19159169
[No Abstract] [Full Text] [Related]
30. Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: a community practice experience.
Shen H; Lipka S; Katz S
J Crohns Colitis; 2014 Aug; 8(8):898-9. PubMed ID: 24434182
[No Abstract] [Full Text] [Related]
31. Adalimumab for the treatment of pediatric Crohn's disease.
Nuti F; Fiorino G; Danese S
Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
[TBL] [Abstract][Full Text] [Related]
32. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
Broge T; Nguyen N; Sacks A; Davis M
Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
[No Abstract] [Full Text] [Related]
33. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
[TBL] [Abstract][Full Text] [Related]
34. Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.
Emmert MY; Salzberg SP; Emmert LS; Behjati S; Plass A; Felix C; Falk V; Gruenenfelder J
Eur J Heart Fail; 2009 Nov; 11(11):1106-9. PubMed ID: 19875411
[TBL] [Abstract][Full Text] [Related]
35. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
Casanova MJ; Chaparro M; Valenzuela C; Cisneros C; Gisbert JP
World J Gastroenterol; 2015 Feb; 21(7):2260-2. PubMed ID: 25717268
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Behm BW; Bickston SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
[TBL] [Abstract][Full Text] [Related]
37. Crohn's disease: Adalimumab improves quality of life.
Papadakis KA
Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):200-1. PubMed ID: 19347008
[No Abstract] [Full Text] [Related]
38. Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease.
Eder P; Lykowska-Szuber L; Krela-Kazmierczak I; Stawczyk-Eder K; Linke K
Acta Gastroenterol Belg; 2013 Mar; 76(1):74-5. PubMed ID: 23650791
[No Abstract] [Full Text] [Related]
39. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.
Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635
[No Abstract] [Full Text] [Related]
40. IBD: Mucosal healing--EXTENDing our knowledge in Crohn's disease.
Danese S; Peyrin-Biroulet L
Nat Rev Gastroenterol Hepatol; 2012 Apr; 9(6):309-11. PubMed ID: 22525828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
